Ondansetron HCL 4 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB26FV3T0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,531
Award facts
- Contract value 100% obligated
- $10,531.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ondansetron HCL 4 mg tablets (500 count) with a contract ceiling value of $10,531.43. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract is set to complete by November 4, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a widely used antiemetic medication critical for military and federal healthcare systems to manage nausea and vomiting in patient populations.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of contract awards with the Defense Logistics Agency Medical Supply Chain, delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FV3T0?
SPE2DB26FV3T0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FV3T0 worth?
The government has obligated $10,531 on SPE2DB26FV3T0.
Is contract SPE2DB26FV3T0 an order under another contract?
Yes. SPE2DB26FV3T0 is a delivery order under SPE2DB20D3104, an indefinite delivery contract.
Was contract SPE2DB26FV3T0 competed?
The extent of competition for SPE2DB26FV3T0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award